Polymorphonuclear leukocyte (PMN) and mononuclear cell (MNC) locomotion was investigated in patients with psoriasis vulgaris before and after treatment with oral photochemotherapy (PUV A) and was found to be significantly increased (PMN: p < 0.001; MNC: p < 0.002) when compared to healthy controls. No significant difference was observed in the locomotion of PMN or MNC before and after PUV A treatment. These results indicate that PMN and MNC locomotion is increased in psoriasis vulgaris and remains unaltered by PUV A treatment.
Psoriatic plaques contain increased amounts of a complement dependent chemotactic factor which might be responsible for the accumulation of polymorphonuclear leukocytes (PMN) in psoriatic skin lesions [1] . Wahba et al [2] demonstrated an enhanced chemotactic response of circulating PMN obtained from untreated patients with psoriasis. In contrast Krueger, Hill, and Jederberg failed to demonstrate increased locomotion activity of PMN [3] in psoriasis but reported an increased chemotactic response of circulating mononuclear cells (MNC) [ 4] .
This study was performed in order to investigate whether photochemotherapy (PUV A) [5] affects the locomotion ability of circulating MNC and PMN in psoriatic patients.
MATERIALS AND METHODS

Subjects
A total of 98 individuals was studied, 44 patients with psonas1s vulgaris (stable plaque type) and 54 healthy volunteers. ALL of the psoriatic patients were untreated for at least 30 days prior to the investigations and had 30 to 50% of the body surface involved.
Mononuclear cell (MNC) locomotion was studied in a total of 21 psoriatic patients, 7 females (f) , 14 males (m), age: 37.4 ± 4.1 years (yr;) mean (x) ± standard error of the mean (SEM) prior to the treatment. Ten patients out of this group (5 m, 5 f; x age 38.1 ± 3.94 yr) were also investigated after co mplete clearing by oral photochemotherapy (PUVA); total UVA dose delivered: 64.2 ± 12.4 Joules/cm 2 25 healthy age-and sex-matched volunteers served as controls. Polymorphonuclear leucocyte (PMN) locomotion was determined in an identical set up in the remaining 23 psoriatic patients, 10 f, 13m; x age: 40.7 ± 13.7 yr; in 12 patients out of this group, 7 f, 5 m; x age 29.5 ± 4.2 yr before PUV A and after PUVA clearing phase (total UV A dose: 72.9 ± 9.9 Joules/cm 2 ) and in 29 healthy volunteers. Photochemotherapy (PUVA) was performed using a PUVA 4000 irrad iation unit (Waldmann, Schwenningen, Germany). After phototesting [6] There was an interval of at least 24 hl" between the last PUV A exposul"e and the locomotion assays.
LOCOMOTION ASSAY MNC were isolated from heparinized venous blood by Ficoll Hypaque separation [7] and PMN were gained by sedimentation of heparinized venous blood with 2% Dextran 500 (Pharmacia, Uppsala, Sweden) [8) . Contaminating erythrocytes were lysed by 0.84% NR,Cl; cells were washed 3 times in medium RPMI 1640 (Flow Laboratories, Bonn, Gemany) containing 100 IU penicillin per rnl, 100 p.g streptomycin (Gibco, Glasgow, Scotland) per rnl, 2% bovine serum albumin (Fluka, Buchs, Switzerland) and were then adjusted in medium to a concentration of 2 X 10 6 cells/rnl. T:rypan blue exclusion revealed more than 94% viable cells, in all experiments.
Locomotion was determined by a modification [9] of Boyden's [10] miCI"opore ftlter technique. 0.5 m1 of cell suspensions were placed in the upper compartment ofthe chemotaxis chamber; 1.5 m1 of a pooled normal human serum, activated by incubation with zymosan (Koch Light Laboratories Colnbrook, Bucks UK) and diluted in gelatine verona! buffered saline (pH7 .3) according to Clark and Kelbanoff [11] , served as cytotaxin in the lower compartment. Filters, 5 p.m and 3 p.m pore size (Millipore Corporation, Bedford, Massachusetts, USA), were used for the determination ofMNC and PMN locomotion, respectively. After incubation for 120 min at 37°C, filters were detached, stained with hemalwn and the cells present on the lower side of the filters were counted in 20 oil immersion fields. Assays were performed in triplicate and the results were expressed as locomotion index (Ll) = mean number of cells<iJ immersion field ± SEM. The random mobility of the cells was evaluated by determining the L1 using gelatine verona! buffered saline (without the cytotaxin)-in the lower compartment of the chemotaxis chamber.
Statistical analysis was performed by the Student's t-test.
RESULTS
The results are listed in detail in the DISCUSSION The significant increase in the response of psoriatic PMN to zymosan activated serum as chemoattractant in this study supports the finding of Wahba et al [2] and indicates that both an increased susceptibility of circulating PMN to chemoattractants in psoriasis plus an increased amount of chemotactic factors produced in psoriatic epidermis, as reported recently [1] , are responsible for the presence ofPMN in psoriatic stratum corneum. study, Krueger et al [3] were unable to demonstrate an increased PMN locomotion ability in psoriasis. Obviously these differences remain to be clarified although they might be explained by the slightly different experimental approaches employed. 8-methoxypsoralen plus long-wave ultraviolet (UV A) radiation as used in photochemotherapy (PUV A) has been shown to influence both MNC [12] and PMN in vitro [13] as well as in vivo in some patients [14] . Although the present study supports previous findings of an increased MNC locomotion ability in untreated psoriasis it failed to show significant differences in the locomotion ability of PMN and MNC in psoriatic patients before and after clearing of the skin lesions by intensive 4 times per week PUV A treatment leading to a 1 + 2 + erythema. This indicates that PUV A may not influence circulating PMN and MNC in vivo, at least as locomotion ability is concerned. Since PUV A treatment leads to a rapid clearing of psoriatic skin lesions including early disappearance of PMN foci both in psoriasis vulgaris [5] and pustular psoriasis (Zumbusch) [15] , one could hypothesize that PUV A may stop the accumulation of PMN in psoriatic epidermis rather by an effect in epidermal production of chemoattractants [16] than by a direct influence of the circulating polymorphonuclear cells.
